115 related articles for article (PubMed ID: 7697574)
1. Maximizing the benefits of thrombolytic therapy for acute myocardial infarction.
Cairns J; Armstrong PW; Belenkie I; Hirsh J; Johnstone DE; Knudtson M; Lemieux M; Massel D; Naylor CD; Roy L
CMAJ; 1995 Mar; 152(6):819-22. PubMed ID: 7697574
[TBL] [Abstract][Full Text] [Related]
2. Time to treatment with thrombolytic therapy: determinants and effect on short-term nonfatal outcomes of acute myocardial infarction. Canadian GUSTO Investigators. Global Utilization of Streptokinase and + PA for Occluded Coronary Arteries.
Cox JL; Lee E; Langer A; Armstrong PW; Naylor CD
CMAJ; 1997 Feb; 156(4):497-505. PubMed ID: 9054819
[TBL] [Abstract][Full Text] [Related]
3. Thrombolytic therapy: overview of results in major vascular occlusions.
Marder VJ
Thromb Haemost; 1995 Jul; 74(1):101-5. PubMed ID: 8578440
[TBL] [Abstract][Full Text] [Related]
4. [Thrombolytic therapy in acute myocardial infarct--is it being used to the fullest?].
Carôla B; Calçada-Correia L; Pedro PG; Conduto R; Dionísio I; Fiuza M; Dias E; Vaz Carneiro A; Amador MG; de Pádua F; Lopes MG
Rev Port Cardiol; 1996 Dec; 15(12):867-76, 863. PubMed ID: 9052962
[TBL] [Abstract][Full Text] [Related]
5. Thrombolytic therapy: pre- and post-GISSI-2, ISIS-3, and GUSTO-1.
Hennekens CH
Clin Cardiol; 1994 Jan; 17(1 Suppl 1):I15-7. PubMed ID: 8156657
[TBL] [Abstract][Full Text] [Related]
6. Age-related trends (1986-1993) in the use of thrombolytic agents in patients with acute myocardial infarction. The Worcester Heart Attack Study.
Chandra H; Yarzebski J; Goldberg RJ; Savageau J; Singleton C; Gurwitz JH; Gore JM
Arch Intern Med; 1997 Apr; 157(7):741-6. PubMed ID: 9125005
[TBL] [Abstract][Full Text] [Related]
7. [t-PA in thrombolytic therapy of acute myocardial infarct].
Rutsch W; Schmutzler H
Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy.
Collen D; Lijnen HR
Thromb Haemost; 1995 Jul; 74(1):167-71. PubMed ID: 8578451
[TBL] [Abstract][Full Text] [Related]
9. Thrombolytic therapy for acute myocardial infarction in the 1990s.
Effron MB; Morales RE
Md Med J; 1991 Jun; 40(6):485-91. PubMed ID: 1830634
[TBL] [Abstract][Full Text] [Related]
10. [Results of treatment of acute myocardial infarction with thrombolytic therapy. Experiences in 437 patients in the coronary care unit of the National Institute of Cardiology "Ignacio Chavez"].
Juárez Herrera U; Lasses y Ojeda LA; López MC; Chuquiure E; González Pacheco H; Carrillo Calvillo J; Martínez Sánchez C; Lupi Herrera E
Arch Inst Cardiol Mex; 1998; 68(5):411-20. PubMed ID: 10365238
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of intravenous thrombolytic drugs for acute myocardial infarction.
Naylor CD; Bronskill S; Goel V
Can J Cardiol; 1993; 9(6):553-8. PubMed ID: 8221354
[No Abstract] [Full Text] [Related]
12. [Evaluation of the cost-effectiveness of thrombolytic therapy in acute myocardial infarct using tissue plasminogen activator or streptokinase:the Italian perspective].
Lorenzoni R; Fattore G; Gensini G
G Ital Cardiol; 1997 Jul; 27(7):721-6. PubMed ID: 9303862
[TBL] [Abstract][Full Text] [Related]
13. Coronary thrombolysis: hemorrhagic complications.
Hirsh J
Can J Cardiol; 1993; 9(6):505-11. PubMed ID: 8221344
[No Abstract] [Full Text] [Related]
14. [Development of new thrombolytic substances].
Zeymer U; Neuhaus KL
Herz; 1994 Dec; 19(6):314-25. PubMed ID: 7843688
[TBL] [Abstract][Full Text] [Related]
15. [Thrombolytic treatment of acute myocardial infarct. 1].
Soares-Costa JT; Soares-Costa TJ; Gabriel HM
Acta Med Port; 1998 May; 11(5):409-19. PubMed ID: 9951051
[TBL] [Abstract][Full Text] [Related]
16. [Myocardial infarction treated within 4 hrs: comparison of the cost-benefit ratio of 3 thrombolytic treatments: APSAC, rt-PA and streptokinase in 270 patients].
Machecourt J; Cassagnes J; Bassand JP; Dumoulin J; Calop J; Foroni L; Terrisse MP; Hénon T; Petit L; Denis B
Arch Mal Coeur Vaiss; 1993 Feb; 86(2):209-17. PubMed ID: 8363422
[TBL] [Abstract][Full Text] [Related]
17. Heparin as an adjuvant to thrombolytic therapy in acute myocardial infarction.
Metz BK; Topol EJ
Biomed Pharmacother; 1996; 50(6-7):243-53. PubMed ID: 8952863
[TBL] [Abstract][Full Text] [Related]
18. Improved health benefits of increased use of thrombolytic therapy.
Fendrick AM; Ridker PM; Bloom BS
Arch Intern Med; 1994 Jul; 154(14):1605-9. PubMed ID: 8031208
[TBL] [Abstract][Full Text] [Related]
19. The safety of automatic versus manual blood pressure cuffs for patients receiving thrombolytic therapy.
Saul L; Smith J; Mook W
Am J Crit Care; 1998 May; 7(3):192-6. PubMed ID: 9579244
[TBL] [Abstract][Full Text] [Related]
20. [Thrombolytic therapy in acute myocardial infarction--update].
Jaffe R; Gotsman MS; Zahger D
Harefuah; 1996 Jun; 130(11):751-7. PubMed ID: 8794679
[No Abstract] [Full Text] [Related]
[Next] [New Search]
